Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting


You May Also Like

Franciscan Alliance, Circulation Unveil Non-Emergency Transportation Partnership

MISHAWAKA, Indiana, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Hospital patients with ongoing medical conditions ...

Cara Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

STAMFORD, Conn., March 15, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology ...